Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 1:16 PM
Ignite Modification Date:
2025-12-26 @ 1:16 PM
NCT ID:
NCT02058706
Group ID:
EG000
Title:
Arm A (Enzalutamide and LHRH Analogue Therapy)
Description:
Patients receive enzalutamide orally PO QD and undergo orchiectomy or receive LHRH analogue therapy (leuprolide acetate, goserelin acetate, or any other FDA approved preparation). Treatment continues in the absence of disease progression or unacceptable toxicity.
enzalutamide: Given PO
orchiectomy: Undergo orchiectomy or receive LHRH analogue therapy
leuprolide acetate: Undergo orchiectomy or receive LHRH analogue therapy
goserelin acetate: Undergo orchiectomy or receive LHRH analogue therapy
laboratory biomarker analysis: Correlative studies
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
17
Serious Number At Risk:
36
Other Number Affected:
33
Other Number At Risk:
36
Study:
NCT02058706
Results Section:
NCT02058706
Adverse Events Module:
NCT02058706